Zakai Neil A, McClure Leslie A, Judd Suzanne E, Kissela Brett, Howard George, Safford Monika, Cushman Mary
Neil A. Zakai, MD MSc, University of Vermont Larner College of Medicine, 360 South Park Drive, Colchester, VT 05446, USA, Tel.: +1 802 6563154, Fax: +1 802 656 8965, E-mail:
Thromb Haemost. 2017 Feb 28;117(3):618-624. doi: 10.1160/TH16-07-0519. Epub 2016 Dec 22.
D-dimer, a biomarker of coagulation, is higher in blacks than in whites and has been associated with stroke and coronary heart disease (CHD). It was our objective to assess the association of higher D-dimer with stroke and CHD in blacks and whites. REGARDS recruited 30,239 black and white participants across the contiguous US and measured baseline D-dimer in stroke (n=646) and CHD (n=654) cases and a cohort random sample (n=1,104). Cox models adjusting for cardiovascular risk factors determined the hazard ratio (HR) for increasing D-dimer for cardiovascular disease with bootstrapping to assess the difference in HR for CHD versus stroke by race. D-dimer was higher with increasing age, female sex, diabetes, hypertension, pre-baseline cardiovascular disease and higher C-reactive protein (CRP). Accounting for cardiovascular risk factors, each doubling of D-dimer was associated with increased stroke (hazard ratio [HR] 1.15; 95 % confidence interval [CI] 1.01, 1.31) and CHD (HR 1.27; 95 % CI 1.11, 1.45) risk. The difference in the HR between CHD and stroke was 0.20 (95 % CI >0.00, 0.58) for blacks and 0.02 (95 % CI -0.30, 0.27) for whites. CRP mediated 22 % (95 % CI 5 %, 41 %) of the association between D-dimer and CHD and none of the association with stroke. Higher D-dimer increased the risk of stroke and CHD independent of cardiovascular risk factors and CRP, with perhaps a stronger association for CHD versus stroke in blacks than whites. These findings highlight potential different pathophysiology of vascular disease by disease site and race suggesting potential further studies targeting haemostasis in primary prevention of vascular disease.
D - 二聚体是一种凝血生物标志物,在黑人中比白人更高,且与中风和冠心病(CHD)有关。我们的目的是评估黑人与白人中较高的D - 二聚体与中风和冠心病的关联。REGARDS研究在美国本土连续招募了30239名黑人和白人参与者,并测量了中风患者(n = 646)、冠心病患者(n = 654)以及队列随机样本(n = 1104)的基线D - 二聚体水平。通过调整心血管危险因素的Cox模型确定了D - 二聚体升高导致心血管疾病的风险比(HR),并通过自抽样评估不同种族冠心病与中风的风险比差异。随着年龄增长、女性、糖尿病、高血压、基线前心血管疾病以及C反应蛋白(CRP)升高,D - 二聚体水平更高。在考虑心血管危险因素的情况下,D - 二聚体每增加一倍,中风风险增加(风险比[HR] 1.15;95%置信区间[CI] 1.01,1.31),冠心病风险增加(HR 1.27;95% CI 1.11,1.45)。黑人中冠心病与中风的风险比差异为0.20(95% CI >0.00,0.58),白人中为0.02(95% CI -0.30,0.27)。CRP介导了D - 二聚体与冠心病关联的22%(95% CI 5%,41%),与中风关联无介导作用。较高的D - 二聚体增加了中风和冠心病的风险,与心血管危险因素和CRP无关,黑人中冠心病与中风的关联可能比白人更强。这些发现凸显了血管疾病在疾病部位和种族方面潜在的不同病理生理学,提示在血管疾病一级预防中针对止血进行潜在进一步研究的必要性。